{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL-6",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00997",
      "entity_text" : "anti-IL-6R antibody",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Recently, IL-6 antagonists (anti-IL-6R antibody) have been developed to block IL-6 from binding to its receptor, IL-6R, and ameliorate inflammation.",
  "reading_complete" : "2020-07-28T14:40:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:39:29Z",
  "trigger" : "block",
  "evidence" : [ "anti-IL-6R antibody) have been developed to block IL-6" ],
  "pmc_id" : "5801042",
  "score" : 0
}